The New Mexico Biotechnology & Biomedical Association (NMBio) Board of Directors is a volunteer group of scientists, academics and other professionals dedicated to the advancement of bioscience in New Mexico and the promotion of New Mexico’s capabilities internationally. The NMBio membership elects eight innovative thinkers and community leaders to the board every year. During their two-year terms, directors are involved in NMBio-sponsored programs and events, policy development, and a variety of committee assignments.
The Executive Director provides leadership and guidance to expand and represent the organization to the community.
Board of Directors
Director of Project Development
Technology Ventures Corporation
andres.salazar AT lmco DOT com
Andrew Salazar is Director of Project Development at Technology Ventures Corporation. He brings a broad range of commercial experience to assist start ups in structuring a realistic approach to success. He has held responsibilities in a variety of disciplines including management positions in engineering, manufacturing, finance, sales and economic development. Throughout his career, Mr. Salazar has focused on bringing together the top-flight resources needed for business success. He holds a BSME with an EE option from General Motors Institute (now Kettering University), an MBA from Stanford University, and is a registered patent agent in the U.S. Patent and Trademark Office. Andrew also serves as the Board President-Elect of New Mexico Math, Engineering and Science Achievement (NM MESA), and also serves on the Board of Advisors for both the Intelligent Imaging Initiative and the New Mexico Small Business Innovative Research (SBIR) Resource Center.
NMBio Vice President
Director, Product Management
TriCore Reference Labs
Mr. VanNess works integrally with TriCore’s team responsible for building and releasing its new business, Diagnostic Optimization. TriCore is attempting to redefine its position in the healthcare market and Mr. VanNess is an essential member in assuring the right products are brought to market to assure customers find it valuable, useful, and assists the volume to value shift within healthcare. He evaluates new opportunities, directs the strategy, and ensures overall product success by working closely with customers and team members. Previously he was the Clinical Coordinator at VisionQuest Biomedical and released is commercial teleretinal screening application. Additionally, Mr. VanNess is the innovator and project manager of an SBIR award to develop a new device for assessing mild traumatic brain injury. He holds a MS in Pharmaceutical Sciences from the University New Mexico, and a BS in Environmental Health at New Mexico State University.
Peacock Myers P.C.
jvilven AT PeacockLaw DOT com
Janeen is Elections Committee Chair for NMBio
Janeen Vilven-Doggett practices in the areas of litigation and transactional matters. She is a member of the New Mexico bar and a registered patent attorney. Dr. Vilven-Doggett received her B.A. in Biology from Baylor University in 1986 and her Ph.D. in Biomedical Sciences from the University of New Mexico in 1997. She received her J.D. (cum laude) from the University of New Mexico School of Law in 2001.
Dr. Vilven-Doggett has experience both as an attorney and as a research scientist. Janeen is a well-known and experienced intellectual property practioner and has been so recognized in Best Lawyers in America. Prior to becoming an attorney, she spent about 13 years as a research scientist at both Baylor College of Medicine (Department of Molecular Physiology and Biophysics), and the University of New Mexico Health Sciences Center (Department of Pediatrics and Department of Pathology). for a comprehensive listing of Dr Vilven Doggett’s publications, please visit here.
Director of Operations
michael AT massbiolab DOT com
Michael is a graduate of the University of New Mexico’s Anderson Schools of Management with a BBA in Financial Management. Vickers manages the day to day operations for Maas Biolab, LLC and oversees the company’s several ongoing drug development projects including good manufacturing practices production of Maas Biolab’s cyclosporine formuation Mitogard(R), good laboratory practices dose range finding toxicology studies and compilation of an Investigational New Drug (IND) application under the company’s current SBIR project. Mr. Vickers co-authored Maas Biolab’s successful grant proposals including a National Insitutes of Health (NIH) fast track SBIR grant as well as a Fort Detrick Tech Transfer Initiative grant. Michael also managed the company’s Defense Threat Reduction Agency (DTRA) contract studying the brain penetration and effectiveness of cyclosporine in models of nerve agent exposure.
Mark Burge, M.D.
Deputy-Director, UNM Health Science Center Clinical & Translational Science Ctr.
UNM Health Sciences Center
mburge AT salud DOT unm DOT edu
Mark Burge, MD, is an Endocrinologist and Diabetes researcher at the University of New Mexico Health Sciences Center. He graduated from the University of Oregon in 1983 and the Oregon Health Sciences University in 1987. After completing residency training in Internal Medicine at the University of Wisconsin in 1991, he pursued his Endocrinology training at UNM HSC and joined the faculty in 1993, achieving Professorship in 2007. Dr. Burge specializes in clinical diabetes studies designed to elucidate mechanisms of the complications of the disease and to improve its treatment. He is also the Deputy Director of UNM HSC’s Clinical and Translational Science Center, an NIH-funded center designed to provide critical infrastructure for clinical researchers and to hasten the development of new and innovative treatments for diseases that affect New Mexicans.
President and CEO
tdunlay AT intellicyt DOT com
Terry Dunlay is the President and CEO of IntelliCyt Corporation, a life science technology company located in Albuquerque. He is an experienced life science entrepreneur with over 20 years of experience in technology development and commercialization. Previously, Terry was co-founder of Cellomics, Inc. where he invented and commercialized the company’s cell-based screening instrumentation and informatics products and held senior management positions, including Executive Vice President. Prior to Cellomics, Terry was founder and CEO of Biological Detection, Inc. a bio-imaging software company and earlier was Vice President of Biological Detection Systems, Inc. a bio-imaging systems, software, and reagents company. Terry has a BS and MS in Electrical Engineering. He holds numerous patents in the area of cell-based screening instrumentation and informatics.
Chief of Clinical Manufacturing
VA Cooperative Studies Program
jan DOT hickey AT va DOT gov
Jan serves as the Chief of Clinical Manufacturing for the Department of Veterans Affairs, Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center leading a team that primarily manufactures tablets and capsules for VA, NIH, and DOD clinical trials. Jan offers roughly 37 years of experience in regulatory affairs, quality, manufacturing, business development and contract manufacturing in FDA regulated industry including drugs, biologics and medical devices. She started her career as an FDA Investigator in the Boston and Denver offices enjoying the opportunity to conduct a wide variety of inspections. She moved to industry when she joined COBE Laboratories in Lakewood, Colorado, a critical medical device manufacturer. Jan had the good fortune to work for small companies at critical times in their development giving her the opportunity to acquire knowledge quickly and be the sole contributor or a team member on many successful activities including 510(k)s, a PMA, CMC sections for drugs and biologics, the transfer of a facility from Virginia to NM, PAIs, landing major contracts and much more. Jan graduated from UNM with a B.S. in Biology and a B.A. in Journalism. She received an M.S. in Science Communications from Boston University.
Miranda Huang Intrator
Bioscience Lead Business Development Executive
Feynman Center for Innovation at Los Alamos National Laboratory
Miranda Huang Intrator is the bioscience lead business development executive at Feynman Center for Innovation at Los Alamos National Laboratory, responsible for developing agile partnerships to complement and grow Los Alamos’ bioscience portfolio. Miranda spent her formative academic years studying mathematics and art history at the University of California at Santa Cruz, and holds a Master’s in Bioengineering from the University of Colorado Anschutz Medical Campus. Prior to her time at the Feynman Center, Miranda performed graduate research in the fields of drug delivery for breast cancer therapy, and ultrasound tomography for breast cancer detection.
CEO and Chief Economic Development Officer
Lisa Kuuttila joined STC.UNM (STC), the University of New Mexico’s technology-transfer program, as President & CEO in 2003. She is currently CEO & Chief Economic Development Officer of the organization. She works with the STC.UNM Board of Directors in developing strategies for implementing STC’s vision to play a vital role in New Mexico’s economic development and to be a leader in technology commercialization. Under her leadership, STC.UNM is substantially growing its program using the Rainforest model to develop an innovation ecosystem in New Mexico. In 2013, STC.UNM was tasked by the University with implementing its economic development initiatives under Lisa’s leadership.
Ms. Kuuttila has more than 30 years of prior leadership experience in technology commercialization and licensing. This includes positions as Assistant Vice President for Technology Commercialization at Purdue Research Foundation; Director, Technology Commercialization, University of Georgia; and Director, Office of Technology Commercialization, Center for Advanced Technology Development, Iowa State University. Her prior experience also includes a consulting practice that provided strategic marketing and technology-transfer consulting services for a wide variety of well-known technology corporations, universities and foundations, including Stanford University. She began her career in industry in several engineering and technology-marketing positions. Lisa received a B.S. Electrical Engineering from the University of Michigan and an M.S. in Public Administration from Iowa State University. She is also a graduate of the Venture Capital Institute.
Richard S. Larson, MD, PhD
Executive Vice chancellor and Vice Chancellor for Research
University of New Mexico Health Sciences Center
rlarson AT salud.unm DOT edu
Dr. Larson is the recipient of the College of American Pathology Lansky Award for his leadership in and contribution to the practice of pathology, UNM Regents Lectureship for contribution to UNM, and American Cancer Society Designated National Investigator for the Coaches against Cancer and Hoops for Lymphoma/Leukemia. One of his publications was chosen as manuscript of the year and appeared in the 2002 Yearbook of Pathology and Laboratory Medicine. Dr. Larson received both his MD and PhD from Harvard University. He did his residency training at Washington University at St. Louis, and his fellowship training at Vanderbilt University. He is a board-certified physician. He maintains a peer-reviewed, funded laboratory as well as his administrative duties. His research interests include biochemical mechanisms of inflammation, viral detection, and new drug discovery. He has published over 80 manuscripts involving basic science, clinical, and translational research. His book Bioinformatics and Drug Discovery was published by Humana Press in 2005. He is active in national cooperative groups, and research organizations. He was the founder of Cancer Services of New Mexico. He is a Chairman of the Board of Directors for TriCore Reference Laboratories as well as a member of the National Center for Genome Resources Board of Directors.
Wayne brings more than 30 years of experience in the pharmaceutical industry, serving in positions of clinical development, business development, U.S. and international commercial development, marketing, sales and chief operating officer. He has had responsibility for the commercialization and product introductions of numerous products in the U.S. and abroad. Wayne has held positons of increasing responsibility at Pifizer, predecessor companies of Sanofi-Aventis, Otsuka, Myriad Genetics, and Myrexis. He is currently President and CEO of Zocere, Inc., a biotechnology company engaged in research and development of stroke therapies, and he is an advisor to Exovita, a biotechnology company researching cancer therapies. He is a member of the Board of Trustees of the National Museum of Nuclear Science and History. He also has served on the board of the National Pharmaceutical Council and as a member of the Chancellor’s Advisory Committee at the University of Maryland.
President and CEO
Santa Fe Business Incubator
A recognized leader in Business Incubation and entrepreneurial development, Marie Longserre has been the President and CEO of the Santa Fe Business Incubator (SFBI) in Santa Fe, New Mexico since its inception in 1997. Under her guidance SFBI added a state of the art shared Bio-Science Lab to the facility in 2014. Marie was twice elected to the Board of the National Business Incubation Association (NBIA) and was Board Chair in 2011-2012. She served on New Mexico Small Business Investment Council for two terms and as NMSBIC Treasurer. She currently represents New Mexico on the Community Development Advisory Council at the Federal Reserve Bank of Kansas City.
Stuart Rose, PhD
The BioScience Center
stuart AT thebiosciencecenter DOT com
Dr. Rose has over 40 years of experience in the pharmaceutical industry. Prior to establishing The BioScience Center in 2012, he served as founder and President/CEO of Oso Biopharmaceutical Manufacturing, a contract manufacturing organization for injectable pharmaceuticals.
Before founding Oso Biopharmaceutical, he held executive positions with Penick Corporation (President/CEO), ICN – now Valeant – Pharmaceuticals (Vice President of Worldwide Manufacturing and VP/GM of ICN Europe), and Par Pharmaceuticals (Senior VP). He spent the majority of his early career with American Cyanamid’s pharmaceutical arm, Lederle Laboratories, where he rose to Vice President of International Manufacturing and Logistics.
Dr. Rose is also a Director of Agilvax, a start-up entity with a novel platform for the development of vaccines; a Director of Oligocide, a start-up developing antimicrobial chemical compounds that attract and then kill bacteria, viruses and some fungi; and an investor/advisor in a number of other biotechnology start-ups. He holds a Ph.D. in Chemistry from Wayne State University in Detroit, Michigan.
Arrowhead Park, Arrowhead Center at New Mexico State University
Wayne is the Executive Director of the Arrowhead Research Park at New Mexico State University, a 175-acre facility currently in development of a healthcare and medical technology industry campus centered around NMSU’s medical research capacities, the Burrell College of Osteopathic Medicine, the Arrowhead Park High School Medical Academy, and a number of tenant partners. The Park provides is a major component of NMSU’s economic development mission.
Wayne is a 1980 graduate of New Mexico State University’s Industrial Engineering program, and a 1994 NMSU Ingeniero Imminente awardee. He has over 30 years of experience in semiconductor manufacturing, high purity gas and chemical production, construction management, and economic development consulting. He has served in a variety of capacities contributing to the successful startup of Spaceport America and the growing commercial space industry, having represented both the New Mexico Spaceport Authority and client/tenant interests. He’s currently serving on the Borderplex Alliance Life Sciences committee
Shannon Sheehan, PhD
NMBio Past President
sm_sheehan AT yahoo DOT com
Dr. Sheehan has first-hand experience moving laboratory inventions to the market. He is an expert in business and economic development and has facilitated the start up of 23 companies. He has worked extensively in the Venture Capital community and has received venture funding and collaborative industry funding for many of his start-up companies. He comes to NMBIO from West Virginia where he served as Interim Director of the Office of Technology Transfer at West Virginia University (WVU). At WVU he cofounded, managed and served on the board of the highly successful WVU Business incubator . Additionally he served on the Steering Committee of the West Virginia Entrepreneurs Forum.
Prior to his role in West Virginia, Dr. Sheehan was a faculty member of the University of Arizona for eleven years. At U of A, Dr. Sheehan published and presented extensively in the field of cytokine regulation of stem cells. Dr. Sheehan received an MBA from the University of Arizona’s top-ranked program and worked in the University’s Office of Technology Transfer where he did market research and licensing.
As Executive Director, Gregory R. Byrnes works on behalf of the New Mexico Biotechnology and Biomedical industry to advocate for its support, accelerate its growth, promote its economic value to members and raise its visibility across the state as well as nationally.
Byrnes career spans 35 years as a journalist, economic development professional, association executive, entrepreneur and consultant. A nationally recognized leader in the field of economic development, Byrnes marketed the greater Philadelphia region as a hub for the life sciences and health care industries in his prior roles as director of Economic & Business Development for PECO Energy and President of the Philadelphia Developers Alliance, a consortium of 21 businesses and the City of Philadelphia.
Byrnes was Vice President of Membership and Business Development as well as a consultant to the Pennsylvania Bio Association. More recently, he served as Director of Corporate Projects for Atlanta-based Conway Data and Site Selection magazine. His consulting assignments include assisting the Chester County Economic Development Council (CCEDC) in strategic planning and fund raising for the county’s Keystone Innovation Zone, which was created to support young entrepreneurial firms in the biotech, information technology and alternative energy sectors. He has served on more than a dozen local, state, regional and national boards of directors, including the Urban Land Institute, Eastern Technology Council, CoreNet Global, and the Team Pennsylvania Foundation.